Skip to content
Company Analysis

Syra Health Corp. SYRA

A comprehensive view of key metrics, scores, and financial health for Syra Health Corp.

Overview of Syra Health Corp.

SYRA OQB
Healthcare Medical Care Facilities Framework: General Corporate Micro Cap
Syra Health Corp. (SYRA), is a Micro Cap company, in the Medical Care Facilities industry, last closed at $0.93, about 24.7% overvalued vs fair value, +1288.1% 1Y return, placing in the top 10% of its sector.
Metrics Rev Growth -9.5% ROE -36.0% Gross Margin 34.4%
USD 0.93
3.33%
(Delayed)
• Vol 90d: 172.7%
52-Week Range
Market Cap
$16.12M
Enterprise Value
$14.07M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Good
Growth
Good
Profitability
Fair
Health
Fair
Efficiency
Weak
Valuation
Good
Completeness: 76%
Confidence: 87%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.syrahealth.com
HQ Carmel, IN
Employees 57
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$1
$1
$1
Current: $0.93 -25% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$7.2M
-9.5%%
Gross Profit
$2.5M
50.5%%
Operating Income
-$904.3K
76%%
Net Income
-$896.3K
76.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio FY2025
50.0%

Operating Cash Flow / Net Income

FCF / Net Income - not meaningful while net income is negative (a near-100% ratio here only reflects cash burn tracking accounting losses, not earnings quality)

Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
0/1
Improving
0
High Impact
1
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Syra Health Corp.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
21
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Strong Liquidity Buffer Liquidity position is strong (score 1.00), providing operational cushion.

Key risks

  • ROIC Below WACC or Peers ROIC at 13.2th percentile suggests inefficient capital deployment.
  • Revenue Volatility Signals Weak Stickiness Revenue volatility is high (stability score 0.02), suggesting weak customer stickiness.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
20
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 88% Coverage
Trade-Off Triangle Visualization A ternary plot showing SYRA's balance between Growth (39.2%), Profitability (18.6%), and Safety (42.2%). Growth 39% Safety 42% Profitability 19%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

52th percentile vs peers
52
Key Signals
Revenue CAGR 3Y 8.8% 68p EPS Growth YoY 84.8% 82p Rev Growth YoY -9.5% 17p
Strengths
  • EPS Growth YoY in top 20% of peers (84.8%, 82th percentile)
  • Current Ratio in top 20% of peers (4.06, 86th percentile)
  • Quick Ratio in top 20% of peers (5.25, 92th percentile)
  • Strong liquidity position vs peers
  • Conservative leverage compared to industry peers
Risks
  • Rev Growth YoY in bottom 20% of peers (-9.5%)

Profitability

24th percentile vs peers
25
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

56th percentile vs peers
56
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Syra Health Corp..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$0.70
- - -
-24.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000